Hantz Financial Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $124K | Buy |
|
|||||
|
2025
Q2 | $108K | Buy |
|
|||||
|
2025
Q1 | $104K | Sell |
|
|||||
|
2024
Q4 | $152K | Sell |
|
|||||
|
2024
Q3 | $7.22M | Sell |
|
|||||
|
2024
Q2 | $7.87M | Sell |
|
|||||
|
2024
Q1 | $10.8M | Sell |
|
|||||
|
2023
Q4 | $9.91M | Sell |
|
|||||
|
2023
Q3 | $8.85M | Buy |
|
|||||
|
2023
Q2 | $9.48M | Buy |
|
|||||
|
2023
Q1 | $9.01M | Buy |
|
|||||
|
2022
Q4 | $9.44M | Buy |
|
|||||
|
2022
Q3 | $8.25M | Sell |
|
|||||
|
2022
Q2 | $9.66M | Buy |
|
|||||
|
2022
Q1 | $12.5M | Sell |
|
|||||
|
2021
Q4 | $20.1M | Buy |
|
|||||
|
2021
Q3 | $20.6M | Buy |
|
|||||
|
2021
Q2 | $15.9M | Buy |
|
|||||
|
2021
Q1 | $11.7M | Buy |
|
|||||
|
2020
Q4 | $9.72M | Buy |
|
|||||
|
2020
Q3 | $8.78M | Buy |
|
|||||
|
2020
Q2 | $6.75M | Buy |
|
|||||
|
2020
Q1 | $4.77M | Buy |
|